Cefpodoxime Proxetil 50 mg / 5mL Granule 100 mL
Reference details for licensed healthcare facility review and verification.
| NDC 11 | 65862-0140-01 |
|---|---|
| Product NDC | 65862-0140 |
| Generic Drug Name | Cefpodoxime Proxetil |
| Brand Name | Cefpodoxime Proxetil |
| Manufacturer | Aurobindo Pharma Limited |
| Strength | 50 mg / 5mL |
| Dosage Form | Granule |
| Drug Type | Oral |
| Package Quantity | 1 Bottle |
| Package Description | 1 BOTTLE in 1 CARTON (65862-140-01) / 100 mL in 1 BOTTLE |
| Active Ingredients | Cefpodoxime Proxetil |
| Marketing Category | ANDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
Cefpodoxime Proxetil 50 mg / 5mL Granule is tracked under NDC 65862-0140-01 and rolls up into product family 65862-0140. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.
- Package configuration: 1 Bottle.
- Manufacturer: Aurobindo Pharma Limited.
- Dosage form: Granule.
- Family size: 3 indexed presentations.
Click a tag to refine the catalog view around this product reference.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Alternate presentations in this family
These nearby package-level pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.
Potential alternatives with matching presentation
Open the comparison hub or review package-level listings from 3 product-NDC families with matching normalized presentation details. Review each product detail page before treating any item as a true alternative.
View Potential Alternative HubCefpodoxime Proxetil 50 mg / 5mL Granule 100 mL Bottle3 package-level listings in the comparison hub.Sample package-level pages in this comparison set
Drug Shortage Information
Public evidence for this exact cefpodoxime NDC includes the strongest official federal context plus product-identification references.
Drug Shortage Index family
View Cefpodoxime Proxetil in the Drug Shortage IndexCompare related NDC-level product references and family-level shortage context for Cefpodoxime Proxetil.This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
Cefpodoxime Proxetil 50 mg / 5mL Granule 100 mL, NDC 65862-0140-01, is a Aurobindo Pharma Limited 50 mg / 5mL granule presentation packaged as 1 Bottle. Historical public shortage information is available for this product reference.
NDC search formats
- Canonical NDC 11: 65862-0140-01
- Digits-only NDC 11: 65862014001
- Possible 10-digit display format: 65862-140-01 (6586214001)
Helpful product links
- Search by brand name: Cefpodoxime Proxetil
- NDC 11: 65862-0140-01
- Product family NDC: 65862-0140
- Compare related presentations: Cefpodoxime Proxetil 50 mg / 5mL Granule 50 mL, Cefpodoxime Proxetil 50 mg / 5mL Granule 75 mL